151 related articles for article (PubMed ID: 19552749)
1. Effects of Schisandra sphenanthera extract on the pharmacokinetics of midazolam in healthy volunteers.
Xin HW; Wu XC; Li Q; Yu AR; Xiong L
Br J Clin Pharmacol; 2009 May; 67(5):541-6. PubMed ID: 19552749
[TBL] [Abstract][Full Text] [Related]
2. Effects of Schisandra sphenanthera extract on the pharmacokinetics of tacrolimus in healthy volunteers.
Xin HW; Wu XC; Li Q; Yu AR; Zhu M; Shen Y; Su D; Xiong L
Br J Clin Pharmacol; 2007 Oct; 64(4):469-75. PubMed ID: 17506780
[TBL] [Abstract][Full Text] [Related]
3. Effect of Schisandra chinensis extract and Ginkgo biloba extract on the pharmacokinetics of talinolol in healthy volunteers.
Fan L; Mao XQ; Tao GY; Wang G; Jiang F; Chen Y; Li Q; Zhang W; Lei HP; Hu DL; Huang YF; Wang D; Zhou HH
Xenobiotica; 2009 Mar; 39(3):249-54. PubMed ID: 19280523
[TBL] [Abstract][Full Text] [Related]
4. A study about drug combination therapy of Schisandra sphenanthera extract and Rapamycin in healthy subjects.
Li R; Guo W; Fu Z; Ding G; Wang Z; Fu H
Can J Physiol Pharmacol; 2012 Jul; 90(7):941-5. PubMed ID: 22686837
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic interactions of almorexant with midazolam and simvastatin, two CYP3A4 model substrates, in healthy male subjects.
Hoch M; Hoever P; Alessi F; Theodor R; Dingemanse J
Eur J Clin Pharmacol; 2013 Mar; 69(3):523-32. PubMed ID: 22990330
[TBL] [Abstract][Full Text] [Related]
6. Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: a phase I, randomized, open-label, crossover study in healthy volunteers.
Krishna G; Moton A; Ma L; Savant I; Martinho M; Seiberling M; McLeod J
Clin Ther; 2009 Feb; 31(2):286-98. PubMed ID: 19302901
[TBL] [Abstract][Full Text] [Related]
7. Cinacalcet does not affect the activity of cytochrome P450 3A enzymes, a metabolic pathway for common immunosuppressive agents : a randomized, open-label, crossover, single-centre study in healthy volunteers.
Padhi D; Salfi M; Emery M
Drugs R D; 2008; 9(5):335-43. PubMed ID: 18721002
[TBL] [Abstract][Full Text] [Related]
8. Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol (acetaminophen) pharmacokinetics in healthy volunteers.
Volak LP; Hanley MJ; Masse G; Hazarika S; Harmatz JS; Badmaev V; Majeed M; Greenblatt DJ; Court MH
Br J Clin Pharmacol; 2013 Feb; 75(2):450-62. PubMed ID: 22725836
[TBL] [Abstract][Full Text] [Related]
9. The Effect of GS-548351 on the Pharmacokinetics of Midazolam Following Multiple Doses of ANS-6637 in Healthy Adults.
Bunn HT; Rosenthal E; Mathur P; McLaughlin M; Proschan M; Vijan A; Aepfelbacher J; Kottilil S; Masur H; Kattakuzhy S; George JM
J Clin Pharmacol; 2020 Dec; 60(12):1598-1605. PubMed ID: 32578227
[TBL] [Abstract][Full Text] [Related]
10. Effect of danshen extract on the activity of CYP3A4 in healthy volunteers.
Qiu F; Wang G; Zhang R; Sun J; Jiang J; Ma Y
Br J Clin Pharmacol; 2010 Jun; 69(6):656-62. PubMed ID: 20565457
[TBL] [Abstract][Full Text] [Related]
11. The effect of ticagrelor on the metabolism of midazolam in healthy volunteers.
Teng R; Butler K
Clin Ther; 2013 Jul; 35(7):1025-37. PubMed ID: 23870610
[TBL] [Abstract][Full Text] [Related]
12. Effect of breviscapine on CYP3A metabolic activity in healthy volunteers.
Zhou X; Gao YY; Hu JY; Dong Y; Zhang HZ; Lai Y
Eur J Clin Pharmacol; 2018 Jan; 74(1):37-44. PubMed ID: 28986606
[TBL] [Abstract][Full Text] [Related]
13. Impact of the Selective Orexin-1 Receptor Antagonist ACT-539313 on the Pharmacokinetics of the CYP3A Probe Drug Midazolam in Healthy Male Subjects.
Berger B; Kaufmann P; Koch A; Dingemanse J
J Clin Pharmacol; 2020 Jul; 60(7):931-941. PubMed ID: 32035014
[TBL] [Abstract][Full Text] [Related]
14. The effect of multiple-dose, oral rifaximin on the pharmacokinetics of intravenous and oral midazolam in healthy volunteers.
Pentikis HS; Connolly M; Trapnell CB; Forbes WP; Bettenhausen DK
Pharmacotherapy; 2007 Oct; 27(10):1361-9. PubMed ID: 17896891
[TBL] [Abstract][Full Text] [Related]
15. Lack of correlation between in vitro inhibition of CYP3A-mediated metabolism by a PPAR-gamma agonist and its effect on the clinical pharmacokinetics of midazolam, an in vivo probe of CYP3A activity.
Fayer JL; Zannikos PN; Stevens JC; Luo Y; Sidhu R; Kirkesseli S
J Clin Pharmacol; 2001 Mar; 41(3):305-16. PubMed ID: 11269571
[TBL] [Abstract][Full Text] [Related]
16. Effect of telaprevir on the pharmacokinetics of midazolam and digoxin.
Garg V; Chandorkar G; Farmer HF; Smith F; Alves K; van Heeswijk RP
J Clin Pharmacol; 2012 Oct; 52(10):1566-73. PubMed ID: 22162542
[TBL] [Abstract][Full Text] [Related]
17. Influence of chronic hepatitis C infection on cytochrome P450 3A4 activity using midazolam as an in vivo probe substrate.
Morcos PN; Moreira SA; Brennan BJ; Blotner S; Shulman NS; Smith PF
Eur J Clin Pharmacol; 2013 Oct; 69(10):1777-84. PubMed ID: 23765407
[TBL] [Abstract][Full Text] [Related]
18. Probe of CYP3A by a single-point blood measurement after oral administration of midazolam in healthy elderly volunteers.
Krupka E; Venisse N; Lafay C; Gendre D; Diquet B; Bouquet S; Perault MC
Eur J Clin Pharmacol; 2006 Aug; 62(8):653-9. PubMed ID: 16832678
[TBL] [Abstract][Full Text] [Related]
19. Effects of oral clotrimazole troches on the pharmacokinetics of oral and intravenous midazolam.
Shord SS; Chan LN; Camp JR; Vasquez EM; Jeong HY; Molokie RE; Baum CL; Xie H
Br J Clin Pharmacol; 2010 Feb; 69(2):160-6. PubMed ID: 20233179
[TBL] [Abstract][Full Text] [Related]
20. Effect of simultaneous induction and inhibition of CYP3A by St John's Wort and ritonavir on CYP3A activity.
Hafner V; Jäger M; Matthée AK; Ding R; Burhenne J; Haefeli WE; Mikus G
Clin Pharmacol Ther; 2010 Feb; 87(2):191-6. PubMed ID: 19924124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
